Target intelligence / Profile preview

General transcription factor II-I pseudogene (GTF2IP)

Target: GTF2IP
Molecular classification: Other (Pseudogene)

Overview

This gene is a pseudogene of the general transcription factor II-I family. Pseudogenes do not encode active proteins and, unless otherwise annotated, are not generally considered functional in normal or therapeutic contexts. Genes of the GTF2I family such as "general transcription factor II-I" (GTF2I, ENSG00000152217) are transcription factors involved in regulating gene expression and have known roles in human disease such as Williams-Beuren syndrome[1][3], but the pseudogene variant "general transcription factor II-I pseudogene" is not an active gene product and not considered a therapeutic target[5].

Other names: GTF2IP1General transcription factor IIi pseudogene 1WBSCR7

Beyond the preview

Go deeper on General transcription factor II-I pseudogene (GTF2IP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on General transcription factor II-I pseudogene (GTF2IP).

Explore the full profile